11/21
06:04 am
holx
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas to a "neutral" rating.
Low
Report
Hologic (NASDAQ:HOLX) was downgraded by analysts at BNP Paribas to a "neutral" rating.
11/11
11:41 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
11/11
11:41 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
11/4
07:21 am
holx
Hologic (NASDAQ:HOLX) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Hologic (NASDAQ:HOLX) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
10/23
08:07 am
holx
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at Mizuho. They now have a $78.00 price target on the stock, up previously from $70.00.
Low
Report
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at Mizuho. They now have a $78.00 price target on the stock, up previously from $70.00.
10/23
08:07 am
holx
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at Mizuho. They now have a $78.00 price target on the stock, up previously from $70.00.
Low
Report
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at Mizuho. They now have a $78.00 price target on the stock, up previously from $70.00.
10/23
07:54 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/23
07:54 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/23
05:49 am
holx
Hologic downgraded to Neutral from Outperform at Mizuho
Low
Report
Hologic downgraded to Neutral from Outperform at Mizuho
10/23
05:49 am
holx
Hologic downgraded to Neutral from Outperform at Mizuho
Low
Report
Hologic downgraded to Neutral from Outperform at Mizuho
10/22
11:58 am
holx
Hologic (NASDAQ:HOLX) had its "equal weight" rating reaffirmed by analysts at Stephens. They now have a $76.00 price target on the stock, down previously from $78.00.
Low
Report
Hologic (NASDAQ:HOLX) had its "equal weight" rating reaffirmed by analysts at Stephens. They now have a $76.00 price target on the stock, down previously from $78.00.
10/22
11:58 am
holx
Hologic (NASDAQ:HOLX) had its "equal weight" rating reaffirmed by analysts at Stephens. They now have a $76.00 price target on the stock, down previously from $78.00.
Low
Report
Hologic (NASDAQ:HOLX) had its "equal weight" rating reaffirmed by analysts at Stephens. They now have a $76.00 price target on the stock, down previously from $78.00.
10/22
11:58 am
holx
Hologic (NASDAQ:HOLX) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Hologic (NASDAQ:HOLX) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
10/22
11:51 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/22
11:51 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/22
11:43 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/22
09:31 am
holx
Hologic downgraded to Equal Weight from Overweight at Stephens
Low
Report
Hologic downgraded to Equal Weight from Overweight at Stephens
10/22
09:31 am
holx
Hologic downgraded to Equal Weight from Overweight at Stephens
Low
Report
Hologic downgraded to Equal Weight from Overweight at Stephens
10/22
08:04 am
holx
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $78.00 price target on the stock.
Low
Report
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $78.00 price target on the stock.
10/22
07:00 am
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/21
09:07 pm
holx
Hologic downgraded to Market Perform from Outperform at Raymond James
Low
Report
Hologic downgraded to Market Perform from Outperform at Raymond James
10/21
09:07 pm
holx
Hologic downgraded to Market Perform from Outperform at Raymond James
Low
Report
Hologic downgraded to Market Perform from Outperform at Raymond James
10/21
09:06 pm
holx
Hologic downgraded to Neutral from Overweight at JPMorgan
Low
Report
Hologic downgraded to Neutral from Overweight at JPMorgan
10/21
04:44 pm
holx
Rating for HOLX
Low
Report
Rating for HOLX
10/21
11:54 am
holx
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at BTIG Research.
Low
Report
Hologic (NASDAQ:HOLX) had its "neutral" rating reaffirmed by analysts at BTIG Research.